Sign In
Buy CANF
$3.15
-0.130 (-3.96%)
At Close: Jul 31, 2026
Can Fite Received Approval for COVID-19 Clinical Trial in Israel, Patient Enrollment and Dosing to Commence Immediately
10:30am, Monday, 13'th Apr 2020
Can Fite Received Approval for COVID-19 Clinical Trial in Israel, Patient Enrollment and Dosing to Commence Immediately
Mid-Afternoon Market Update: Crude Oil Up 2%; Biocept Shares Surge
12:00am, Monday, 13'th Apr 2020Can-Fite Reports Positive Top Line Results from its Phase II NASH Study with Namodenoson
01:00pm, Tuesday, 07'th Apr 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory and liver diseases, today announce
Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020
11:00am, Monday, 30'th Mar 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced t
Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020
12:00am, Monday, 30'th Mar 2020The Week In Cannabis: Marijuana Stocks Outperform S&P Again As Weed Is Deemed 'Essential' In COVID-19 Times
08:12pm, Saturday, 28'th Mar 2020
As the coronavirus (COVID-19) pandemic continues to spread, more and more states in the U.S. decide to declare cannabis an “essential” good, just like basic groceries...
Can-Fite Reports 2019 Financial Results & Provides Clinical Development Update
11:00am, Friday, 27'th Mar 2020
Can-Fite Reports 2019 Financial Results & Provides Clinical Development Update
Can-Fite Posts $9.6M Net Loss, Provides Clinical Trials Updates
12:00am, Friday, 27'th Mar 2020BMY, TLRY among premarket gainers
01:21pm, Monday, 23'rd Mar 2020
Waitr Holdings (NASDAQ:WTRH) +51% on expanding into Grocery Delivery.Innate Pharma S.A. (NASDAQ:IPHA) +34% on potential use of cancer drug for Covid-19.DCP Midstream, LP (NYSE:DCP) +31% on cutting
Can-Fite: Piclidenoson is Submitted for Compassionate Use Treatment for Coronavirus Patients in Israel
11:45am, Monday, 23'rd Mar 2020
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced today
Can-Fite Submits its Piclidenoson for Compassionate Use Treatment for Coronavirus Patients in Israel
12:00am, Monday, 23'rd Mar 2020SLS, APRN among premarket gainers
01:23pm, Wednesday, 18'th Mar 2020
Biomerica (NASDAQ:BMRA) +133% on advancement of rapid coronavirus test.IMV (NASDAQ:IMV) +55% on coronavirus vaccine plan.Vaxart (NASDAQ:VXRT) +46% on coronavirus vaccine deal.Blue Apron Holdings (N
Can-Fite to Participate in Digital Bio-Europe Spring Partnering Conference; Looks to Partner on Co-Development for Coronavirus Treatment
